Poll-X
Poll-X is a medicine authorised by Swissmedic under authorisation number 67123. The authorisation holder is axapharm ag. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 04 June 2019 and the authorisation is valid without a time limit. ATC code R06AX27 places the medicine in the group Antihistamines for systemic use.
| Authorisation number | 67123 |
|---|---|
| Name | Poll-X |
| Full name | Poll-X, Filmtabletten |
| Authorisation holder | axapharm ag |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | R06AX27 |
| First authorisation | 04 June 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Poll-X, Filmtabletten | D | 04 June 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 9 | 10 | Tablette(n) | R06AX27 | 07.13.1. | D |
| 10 | 30 | Tablette(n) | R06AX27 | 07.13.1. | D |
| 11 | 50 | Tablette(n) | R06AX27 | 07.13.1. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Poll-X authorised in Switzerland?
Yes. Poll-X is authorised by Swissmedic under authorisation number 67123, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Poll-X have?
Poll-X is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Poll-X?
The authorisation holder is axapharm ag. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.